Enter your login e-mail to the account
Search
Search parameters
Search results
- Pharmacotherapy of rheumatoid arthritis II. – biological therapy
doc. MUDr. Želmíra Macejová, PhD., doc. MUDr. Ivan Rybár, PhD.
(2/2010, Drugs & drug classes ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - Individual approach choosing appropriate therapy for patient with multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(5/2016, Interdisciplinary consilium ) - Actual knowledges of psoriatic arthritis
MUDr. Kristína Brázdilová, PhD., MUDr. Daniel Čierny, PhD., Doc. MUDr. Zdenko Killinger, PhD., prof. MUDr. Juraj Payer, PhD., MPH, FRCP
(2/2017, Interdisciplinary consilium ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium ) - Editoriál
MUDr. Zoltán Szép
(3/2005, Editorial ) - PSORIASIS – NEWS IN PATHOGENESIS AND THERAPY
MUDr. Zoltán Szép
(3/2005, Topic ) - Biologic treatment versus prophylactic treatment of migraine
MUDr. Jana Martinková, PhD.
(3/2021, Interdisciplinary consilium ) - New perspectives of the treatment of migraine
MUDr. Rudolf Kotas, Ph.D.
(3/2019, Interdisciplinary consilium ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA
prof. MUDr. Elena Tóthová, CSc.
(12/2008, Topic )
- Výzkum nových léčiv u Alzheimerovy choroby
PharmDr. Jana Hroudová, Ph.D.
(2/2018, Review articles )
- Therapeutic advances in hereditary muscular disorders
MUDr. Stanislav Voháňka, CSc., MBA
(3/2011, Review articles ) - New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - CGRP monoclonal antibodies for migraine prophylaxis
MUDr. Tomáš Nežádal, Ph.D.
(5/2019, Review articles ) - Experience with shortened ocrelizumab infusion – ENSEMBLE PLUS study
doc. MUDr. Yvonne Benešová, Ph.D.
(1/2022, Review articles ) - The neuromyelitis optica spectrum disorders
doc. MUDr. Jarmila Szilasiová, PhD.
(5/2019, Review articles ) - Anti CD20 multiple sclerosis therapy
Doc. MUDr. Pavel Štourač, Ph.D.
(1/2018, Pharmacotherapy ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Migraine treatment in patients with poor compliance
MUDr. Jana Múdra
(4/2022, Review articles ) - High efficacy treatment since the first attack – an important step in the treatment of multiple sclerosis?
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(1/2023, Review articles ) - The use of anti-CGRP monoclonal antibodies amongst wide variety of patients
MUDr. Markéta Škodová
(1/2023, Review articles ) - The role of B lymphocytes in the immunopathogenesis and treatment of multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(3/2024, Informations ) - The significance of correct algorithm of the diagnostics and treatment of migraine in the prophylactic treatment against calcitonin gene-related peptide
MUDr. Rudolf Kotas, Ph.D., MUDr. Ondřej Slach, MUDr. František Jelínek, MUDr. Jolana Mračková, Ph.D.
(2/2022, Review articles ) - Paraneoplastic syndromes of peripheral nerves, neuromuscular junction and muscles
prof. MUDr. Zdeněk Ambler, DrSc.
(1/2013, Main topic ) - Susac’s syndrome
MUDr. Jiří Piťha , MUDr. Marta Vachová, MUDr. Jana Kotalová, MUDr. Markéta Ceé
(6/2020, Case reports ) - Current options in the treatment of multiple sclerosis
MUDr. Eva Meluzínová
(5/2010, Review articles ) - Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective
Prof. MUDr. Tomáš Kozák, Ph.D.
(6/2016, From the boundary of neurology ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Magnetic resonance imaging for detection of opportunistic infection of patients with multiple sclerosis
doc. MUDr. Dana Horáková, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D.
(6/2016, Review articles ) - Ocrelizumab – what we know, what we can improve now, what we can improve in the future
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Ofatumumab in clinical practice
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Progress in therapy of autoimmune neuropathies
doc. MUDr. Edvard Ehler, CSc. , prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN
(3/2021, Main topic ) - Primární bolesti hlavy – léčba dnes a zítra
MUDr. Jolana Marková , MUDr. Rudolf Kotas, Ph.D.
(3/2018, Review articles ) - Efficacy and safety of ofatumumab in naive MS patients.
MUDr. Martina Martiníková
(5/2023, Informations ) - New perspectives of the treatment of migraine
MUDr. Rudolf Kotas, Ph.D.
(3/2017, Review articles ) - B lymfocyty v roztroušené skleróze mozkomíšní a postavení biologika cílícího na B lymfocyty v její léčbě
prof. RNDr. Jan Krejsek, CSc.
(3/2018, From the boundary of neurology ) - B cells as a target in the treatment of multiple sclerosis
MUDr. Luděk Hochmuth
(3/2017, Review articles ) - TYSABRI – new management of risk factors
MUDr. Yvonne Benešová, Ph.D.
(3/2017, Pharmacotherapy ) - Chronic migraine
MUDr. Tomáš Nežádal, Ph.D.
(2/2019, Review articles ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic ) - Paraproteinaemic neuropathies
prof. MUDr. Egon Kurča, PhD., MUDr. Monika Turčanová Koprušáková, PhD.
(1/2016, Main topic ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - Peripheral neuropathies in malignancies
prof. MUDr. Zdeněk Ambler, DrSc.
(5/2013, Review articles ) - B-cell targeted therapy to impact the progression of multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2023, Review articles ) - MS and NMOSD during the pandemic COVID-19 – what have we already learnt?
MUDr. Dominika Šťastná, MUDr. Ingrid Menkyová, doc. MUDr. Dana Horáková, Ph.D.
(4/2021, Review articles ) - Biologics targeting CD20 molecule on B cells in the therapy of multiple sclerosis patients
Prof. RNDr. Jan Krejsek, CSc.
(6/2022, From the boundary of neurology ) - Migraine – from pathophysiology to monoclonal antibodies
MUDr. Rudolf Kotas, Ph.D.
(4/2019, Review articles ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles ) - The new trends in multiple sclerosis treatment
prof. MUDr. Ľubomír Lisý, DrSc.
(2/2020, Review articles )
- Anti-IgE therapy of severe asthma in children and adolescents
doc. MUDr. Peter Čižnár, CSc.
(3/2012, Case reports ) - CURRENT THERAPY OF INFLAMMATORY BOWEL DISEASES IN CHILDREN
prof. MUDr. Jiří Nevoral, CSc.
(1/2008, Review articles )
- Diagnosis and treatment of nephrotic syndrome in children
doc. MUDr. Sylva Skálová, Ph.D., MUDr. Jakub Zieg, Ph.D.
(3/2017, Review articles )
- Klinická skúsenosť s liečbou mnohopočetného myelómu monoklonálnou protilátkou v monoterapii – kazuistika
MUDr. Natália Štecová
(4/2018, Original articles ) - Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Blastic transformation of indolent lymphomas
MUDr. Jan Hudeček, CSc.
(1/2007, Review articles ) - Systemic treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(3/2013, Main topic ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Lymphoma biologic therapy
MUDr. Andrej Vranovský, PhD.
(1/2011, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - A patient with metastatic colorectal adenocarcinoma treated with chemotherapy in combination with bevacizumab
MUDr. Michal Mego, PhD., MUDr. Zuzana Syčová-Milá, MUDr. Jana Obertová, MUDr. Patrik Palacka, PhD., MUDr. Ján Rajec, PhD., doc. MUDr. Jozef Mardiak, CSc., mim. prof.
(1/2011, Original articles & case reports ) - The genetic profile is determinating the choice of treatment of de-novo patients with chronic lymphocytic leukemia
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD., MUDr. Jozef Lukáš, PhD.
(2/2024, Review articles ) - TREATMENT STRATEGIES FOR CHILDHOOD NON-HODGKIN LYMPHOMA
h. doc. MUDr. Eva Bubanská, CSc.
(2/2008, Review articles ) - HIGH-DOSE THERAPY IN MALIGNANT LYMPHOMAS
MUDr. Andrej Vranovský
(2/2008, Review articles ) - Innovative treatment of chronic lymphocytic leukemia using chemo-free strategies, ringing the bell for chemotherapy?
MUDr. Firas Farkaš, PhD.
(5/2021, Review articles ) - Personalized medicine approach in metastatatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(6/2013, Review articles ) - Biological treatment with monoclonal antibody
MUDr. Andrey Švec, PhD., PharmDr. Andrea Gažová, PhD., prof. PharmDr. Ján Kyselovič, CSc.
(2/2019, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - Gastrointestinal malignancies – current position of imunotherapy
MUDr. Dominik Šafčák, PhD., doc. MUDr. Igor Andrašina, CSc.
(1/2023, Main topic ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Checkpoint inhibitors in treatment of malignant lymphoma
MUDr. Barbora Kašperová
(3/2019, Review articles ) - Treatment and prognosis of patients with hairy cell leukaemia treated in 1996 – 2010 at the National Cancer Institute in Bratislava
MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, MUDr. Radoslav Greksák, PhD., MUDr. Iveta Oravcová, PhD.
(4/2011, Original articles & case reports ) - Publikujeme v zahraničí
(3/2016, Information & comments ) - Anti-EGFR treatment in colorectal cancer – what is ist role today and in the future?
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(5/2019, Review articles ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - Ras genes of metastatic colorectal carcinoma
RNDr. Katarína Hlinková
(4/2014, Review articles ) - Follicular lymphoma: present and perspective in treatment
MUDr. Adriana Kafková, prof. MUDr. Elena Tóthová, CSc.
(3/2017, Spectrum ) - Drug induced osteonecrosis of the upper and lower jaw
MDDr. Marcel Riznič, PhD., PhDr. Martina Lásková, MPH, prof. MUDr. Andrej Jenča, CSc., MPH, MUDr. Jozef Jendruch
(3/2017, Review articles ) - Current possibilities of immunotherapy in non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(3/2020, Review articles ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - New research trends in the tumor cell biology − our research activities
doc. RNDr. Vladimír Zajac, CSc., RNDr. Soňa Čierniková, PhD., RNDr. Ján Sedlák, DrSc., Mgr. Lucia Kučerová, PhD., RNDr. Miroslava Matúšková, PhD., Mgr. Erika Ďuriníková, RNDr. Katarína Szabová, PhD
(1/2015, Main topic ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Current options and perspectives of both adjuvant and neoadjuvant therapy of cholangiocarcinoma
MUDr. Patrik Palacka, PhD., MUDr. Iveta Vochyanová-Andrezálová
(1/2010, Review articles ) - Biological therapy in colorectal cancer
MUDr. Jozef Dolinský
(2/2011, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Treatment of newly diagnosed multiple myeloma
Doc. MUDr. Ľubica Harvanová, PhD., MUDr. Kristína Nemergutová, MUDr. Iveta Simančíková, PhD., MUDr. Ladislav Sopko, PhD., prof. MUDr. Angelika Bátorovová, CSc.
(6/2022, Main topic ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA – STAGING AND TREATMENT (PART 2)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(6/2008, Review articles ) - Mantle cell lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2024, Main topic ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Antitumor immunity
MUDr. Ján Lakota, CSc., MUDr. Milan Žuffa, CSc.
(2/2015, Review articles ) - THE ROLE AND LIMITS OF PATHOLOGY IN ONCOLOGY
prof. MUDr. Lukáš Plank, CSc.
(1/2006, Review articles ) - Establishing diagnosis of hairy cell leukemia (HCL) and identification of the extent of the minimal residual disease (MRD) with flow cytometry of bone marrow aspirate and immunochemistry of trephine biopsy
MUDr. Radoslav Greksák, PhD.
(6/2012, Original articles & case reports ) - Optimal first-line treatment of mCRC
MUDr. Jana Ďurková
(1/2017, Review articles ) - Management of the patient with high-risk multiple myeloma – case report
MUDr. Emília Flochová, PhD.
(S3/2018, Original works & case studies ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Publikujeme v zahraničí
(1/2018, Information & comments ) - Interference with NAT in the treatment of multiple myeloma by monoclonal antibody
MUDr. Marta Kučeráková, MUDr. Mária Laurincová, Mgr. Jana Holienková, Mgr. Jana Králová, MUDr. Martin Písačka
(5/2018, Review articles )
- Interdisciplinary collaboration in the management of patient with hidradenitis suppurativa
MUDr. Barbara Ivanková, MBA, MUDr. Jana Šimonová, PhD., MPH, MUDr. Matúš Baran, MBA, MPH, MUDr. Andrej Figula, MUDr. Veronika Kováčová, MUDr. Natália Humeníková, MSc, MUDr. Mária Tokárová, MSc, MUDr. Tomáš Kampe, PhD., MPH, doc. MUDr. Janette Baloghová, PhD.
(4/2023, Interdisciplinary consilium ) - Psoriasis – yesterday and today
MUDr. Zuzana Baranová, PhD.
(2/2023, Review articles )
- Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Biological drugs from the perspective of pharmacy
PharmDr. Katarína Bruchatá, PhD., Mgr. Peter Heinz
(4/2014, Pharmaceutical technology ) - Treatment of gout, traditional and new pharmacotherapy use
Ján Kamenický, MUDr. Monika Laššánová
(1/2024, Current pharmacotherapy ) - Do CGRPs monoclonal antibodies represent a progress in the prophylaxis of migraine?
doc. RNDr. Ingrid Tumová, CSc.
(1-2/2020, Current pharmacotherapy ) - Natural products to enhance immunity
PharmDr. Silvia Fialová, PhD.
(1/2013, Phytotherapy ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - New therapy options for multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(4/2013, Current pharmacotherapy )
- The importance of Chlamydophila pneumoniae and cytomegalovirus infection in development of carotid plaques
MUDr. Roman Slyško, PhD., MUDr. Ján Tomka, PhD., prof. MUDr. Vladimír Šefránek, PhD., MUDr. Ján Kazár, DrSc., Mgr. Juraj Gašparovič, MUDr. Eva Kováčová, PhD., MUDr. Katarína Daňová
(2/2010, Review articles )